Sanjana Dayal, PhD, and Steven Lentz, MD, PhD, received a $3.36M R01 grant from the National Institute of Allergy and Infectious Diseases. The grant, titled “Cellular Effects of SARS-CoV-2 in Mediating Thrombotic Susceptibility,” will allow Dayal and Lentz to investigate whether an increase in cytokines as a result of COVID-19 can activate blood cells and […]
Sanjana Dayal, PhD, assistant professor in Hematology, Oncology and Blood & Marrow Transplantation, received a $50,000 COVID-19 Pilot Grant from the Roy J. Carver Charitable Trust. This funding will allow Dayal to examine the mechanisms of hypercoagulation in COVID-19 mouse models. Hypercoagulation, also known as excessive blood clotting, tends to occur in COVID-19 patients and often […]
Sanjana Dayal, PhD, Assistant Professor of Internal Medicine, has received a two-year, $200,000 Innovative Project Award (IPA) from the American Heart Association. Dr. Dayal and her research team will investigate how aging-related changes in the gut microbiome affect thrombosis. This novel study will also examine how the antioxidant glutathione peroxidase 1 (Gpx1) alters the gut […]
Dr. Sanjana Dayal, Assistant Professor of Hematology, Oncology, and Blood & Marrow Transplantation, has received supplemental funding through the NIH’s National Institute of Aging to expand her research into the area of Alzheimer’s disease and Alzheimer’s-related dementias. In 2015, she received a 5-year, $1.5M R01 to study age-associated thrombosis. This most recent grant is a […]
I’m pleased to announce that our clinical and research missions will intersect in a new venture. The University of Iowa has been invited to be a clinical site for the Pulmonary Trials Cooperative (PTC) by the National Heart, Lung, and Blood Institute, as part of an effort to fund practical studies in a search for […]